Securing Interim Clinical Leadership During a Critical Post-Funding Scale-Up
02 Jul, 20264 minsA venture-backed European biotechnology company in the respiratory disease space had just cl...
A venture-backed European biotechnology company in the respiratory disease space had just closed a Series A and was entering a high-pressure scale-up phase. The science was strong and the strategy was in place, but the company had a gap that no amount of funding could paper over: hands-on clinical development leadership.
Barrington James had been engaging with this client through proactive talent mapping and senior-level outreach. That exploratory relationship suddenly became urgent when the client's planned Head of Clinical Development hire turned out to be roughly 12 months away from being in post. The search shifted overnight into a targeted hunt for an Interim Head of Clinical Development who could act as a senior right-hand to the CMO and turn strategy into execution, immediately.
The Challenge
Funding success had created its own pressure. Investors expected to see clinical trial activity accelerate fast, and the CMO needed an experienced operator in the room to deliver on that, not in a year, but now. With the substantive clinical development hire still 12 months out, the organisation risked losing momentum at exactly the moment it needed to prove it could execute.
Our Approach
This wasn't a vacancy to fill, it was a problem to solve at speed.
We drew on a targeted search across specialist respiratory and clinical development talent pools and quickly identified a candidate with strong respiratory expertise and a global pharmaceutical background.
From there, the priority was compressing time without compromising quality, applying the same high-touch, discreet approach that underpins our Board & Executive Search practice. That meant:
- Engaging the candidate early to fast-track alignment through the right internal stakeholders
- Designing a tightly managed two-stage interview process built for speed
- Coordinating scheduling and feedback loops continuously to keep the process moving
- Proactively clearing blockers, from availability constraints to contractual steps, before they could cause delay
Results & Client Impact
Interim clinical leadership was secured in 9 days from initial engagement, with the interview-to-offer process completed in just 4 days. The appointed leader gave the organisation the hands-on capacity it needed to keep clinical development on track while the permanent leadership plan continued in the background, without disruption and without losing investor confidence at a sensitive moment.
The bigger story is what happened next. That single placement became the foundation for a long-term strategic partnership: the client went on to engage Barrington James for approximately eight further recruitment solutions placements over the following 14 months, across clinical and specialist functions.
Summary
This is what proactive life science recruitment looks like under real pressure. By combining deep sector knowledge with the ability to move fast when it mattered, Barrington James didn't just bridge a leadership gap; it became a trusted partner for the client's growth.
For biotech and pharma organisations navigating funding milestones, scale-up phases, or unexpected leadership gaps, this is the model: senior-level talent, identified and engaged before the need becomes urgent, and a delivery process built to move at the speed your business actually requires. Whether you need an interim leader in place within days or a long-term recruitment partner who understands your sector inside out, our team is ready to help you hire with the same speed and precision.